XML 48 R32.htm IDEA: XBRL DOCUMENT
v3.24.1

Capital Stock (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2023
Equity [Abstract] |
Schedule of Common Stock Activity | There was no Common Stock activity during the year ended December 31, 2022. The following table provides a summary of Common Stock activity for the year ended December 31, 2023:
Issued Shares as of December 31, 2022 and 2021 |  | 2,070,861 |
Issuances from Preferred Stock conversions |  | 14,102,477 |
Issuances related to warrants |  | 746,027 |
Issuances related to stock compensation |  | 179,535 |
Common shares exchanged for prefunded warrants |  | (406,776) |
Issued Shares as of December 31, 2023 |  | 16,692,124 |
Less Treasury Shares: |  | 7,553 |
Outstanding Shares as of December 31, 2023 |  | 16,684,571 |
Schedule of Warrants Activity | Warrants outstanding as of December 31, 2023 are as follows:
Issue Date |  | Warrants Issued |  | Exercise Price |  | Expiration Date
June 30, 2021 - Series A* |  | 250 |  |  | $ | 60.00 |  |  | January 4, 2024
June 30, 2021 - Series B |  | 750 |  |  | $ | 66.00 |  |  | June 28, 2024
Investor Common Warrants |  | 3,830,417 |  |  | $ | 1.71 |  |  | September 30, 2028
Placement Agent Warrants |  | 306,433 |  |  | $ | 1.71 |  |  | September 30, 2028
|  | 4,137,850 |  |  |  |  |
*The Series A warrant’ expiration date has been updated to reflect the extension described above that occurred on January 3, 2023, and as of the date of this filing, the remaining Series A Warrants have expired.
Warrant activity for the years ended December 31, 2023 and 2022 is presented below:
|  | Outstanding
|  | Number of Warrants |  | Weighted Average Exercise Price
Warrants outstanding and exercisable, December 31, 2021 |  | 343,099 |  |  | $ | 995.06 |
Warrants outstanding and exercisable, December 31, 2022 |  | 343,099 |  |  | 66.34 |
Granted |  | 4,543,626 |  |  | 1.71 |
Exercised |  | (746,027) |  |  | 0.78 |
Expired |  | (2,601) |  |  | 76.93 |
Forfeited |  | (247) |  |  | — |
Warrants outstanding and exercisable, December 31, 2023 |  | 4,137,850 |  |  | $ | 1.73 |

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the change in common stock outstanding. + References No definition available. + Details
Name: | us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-1 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration